Shareholding disclosure

Credit Suisse Funds AG

Declared position

3.91%

Threshold

Crossed upwards

Timeline

Published

05.05.2021

Transaction

27.04.2021

Voting rights breakdown

Voting rights acquired3.91%

Voting rights sold0%

Below threshold0%

Notice details

CategoryCollective investment vehicle

ExchangeXSWX

Notification ID

TCL5300017

Beneficial owner

Credit Suisse Funds AG

Declared address

Credit Suisse Funds AG, Zürich

Open shareholder profile Open company profile

Back to the feed

Shareholding disclosure

Credit Suisse Funds AG

Addex Therapeutics Ltd05.05.2021TCL5300017

Disclosure summary

Credit Suisse Funds AG disclosed a holding in Addex Therapeutics Ltd on the acquisition side, published by SIX Exchange Regulation on 05.05.2021, at 3.91% of voting rights. Notice category: Collective investment vehicle.

Disclosed position

3.91%

Voting rights acquired

Voting rights acquired3.91%

Voting rights sold0%

Below threshold0%

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open

Disclosure detail

Credit Suisse Funds AG disclosed a holding in Addex Therapeutics Ltd, published on 05.05.2021.

Publication date05.05.2021

Transaction date27.04.2021

Issuing companyAddex Therapeutics Ltd

Beneficial ownerCredit Suisse Funds AG

Declared addressCredit Suisse Funds AG, Zürich

CategoryCollective investment vehicle

Voting rights acquired3.91%

Voting rights sold0%

Below threshold0%

ExchangeXSWX

Notification IDTCL5300017

Commercial register

CHE-102.923.465

Struck off the register · 03.05.2024

Zefix record

Source: SIX Exchange Regulation · Publication date: 05.05.2021

These figures aggregate public disclosures. They are not investment advice.

insider24.ch

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open